Chardan Capital Markets initiated coverage on Korro Bio with a new price target
$KRRO
Biotechnology: Pharmaceutical Preparations
Health Care
Chardan Capital Markets initiated coverage of Korro Bio with a rating of Buy and set a new price target of $25.00